- Home»
- The Billing Beat Newsletter»
- Drug Testing For Opioid Treatment and Controlled Substance Monitoring
Drug Testing For Opioid Treatment and Controlled Substance Monitoring
October 25, 2017N.C. Medicaid has drafted a new medical policy outlining the requirements and limits for drug testing for opioid treatment and chronic pain management. N.C. Medicaid held a stakeholder meeting in October 2016 and reviewed the comments, concerns, and suggestions shared by providers at that time. The new policy mirrors Palmetto Local Coverage Determination (LCD), while maintaining fiscal responsibility. Effective Nov. 1, 2017, N.C. Medicaid and N.C. Health Choice (NCHC) shall cover presumptive testing up to 24 times and definitive testing up to 24 times per state fiscal year (July 1-June 30).